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 27 
Abstract 28 
Purpose: Cross-sectional studies suggest that training can increase muscle carnosine (MCarn), 29 
although longitudinal studies have failed to confirm this. A lack of control for dietary β-alanine 30 
intake or muscle fibre type shifting may have hampered their conclusions. The purpose of the 31 
present study was to investigate the effects of high-intensity interval training (HIIT) on MCarn. 32 
Methods: Twenty vegetarian men were randomly assigned to a control (CON; n=10) or HIIT 33 
(n=10) group. HIIT was carried out on a cycle ergometer for 12 weeks, with progressive volume 34 
(6-12 series) and intensity (140-170% lactate threshold [LT]). MCarn was quantified in whole-35 
muscle and individual fibres; expression of selected genes (CARNS, CNDP2, ABAT, TauT and 36 
PAT1) and muscle buffering capacity in vitro (βmin vitro) were also determined. Exercise tests 37 
were performed to evaluate total work done (TWD), VO2max, ventilatory thresholds (VT) and 38 
LT. Results: TWD, VT, LT, VO2max and βmin vitro were improved in the HIIT group (all P<0.05), 39 
but not in CON (p>0.05). MCarn (in mmol·kg-1 dry muscle) increased in the HIIT (15.8±5.7 to 40 
20.6±5.3; p=0.012) but not the CON group (14.3±5.3 to 15.0±4.9; p=0.99). In type I fibres, 41 
MCarn increased in the HIIT (from 14.4±5.9 to 16.8±7.6; p=0.047) but not the CON group 42 
(from 14.0±5.5 to 14.9±5.4; p=0.99). In type IIa fibres, MCarn increased in the HIIT group 43 
(from 18.8±6.1 to 20.5±6.4; p=0.067) but not the CON group (from 19.7±4.5 to 18.8±4.4; 44 
p=0.37). No changes in gene expression were shown. Conclusion: In the absence of any dietary 45 
intake of β-alanine, HIIT increased MCarn content. The contribution of increased MCarn to the 46 
total increase in βmin vitro appears to be small. 47 
 48 
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Introduction 52 
 Hight-intensity interval training (HIIT) is a potent stimulus to improve anaerobic 53 
capacity and tolerance to high-intensity efforts (1). These adaptations appear to be, at least in 54 
part, through an increase in the physiochemical buffering capacity of the muscle cells (2,3) and 55 
by increased H+ removal capacity (4). Evidence from cross-sectional studies show higher 56 
muscle buffering capacity in athletes participating in sports requiring high-intensity efforts in 57 
comparison with athletes participating in sports where efforts are of lower intensity, or with 58 
non-trained individuals (2,5). This has been confirmed by a longitudinal study that showed 59 
improved physiochemical buffering capacity following high-intensity, but not moderate 60 
intensity training (3). Skeletal muscle adaptations that account for the increase in 61 
physiochemical buffering capacity remain unknown but one possibility is an increase in muscle 62 
carnosine (MCarn) content. 63 
Carnosine (β-alanyl-L-Histidine) is a cytoplasmic dipeptide abundantly stored in the 64 
skeletal muscle of many vertebrates, including humans. Carnosine synthesis is catalysed by 65 
carnosine synthase in a reaction that requires the amino acids L-histidine and β-alanine (6). In 66 
human skeletal muscle, β-alanine is the rate-limiting step of carnosine synthesis (7). Increasing 67 
dietary intake of β-alanine results in large increases (~60–80%) in MCarn (7-9). A wide range 68 
of physiological roles have been attributed to carnosine (10), although pH buffering seems to 69 
be particularly relevant within the skeletal muscle under high-intensity exercise, since the pKa 70 
of carnosine (i.e., 6.83) (11) lies close to the midpoint of the pH transit-range (between rest and 71 
fatigue) in exercised skeletal muscle (12). The H+ buffering role of carnosine in skeletal muscle 72 
is also supported by the fact that glycolytic type II muscle fibres have a higher carnosine content 73 
than oxidative type I fibres (13); in humans, carnosine in type II fibres is about 1.5 times higher 74 
than in type I fibres (8). Further evidence to support the pH buffering role of carnosine is 75 
provided by cross-sectional studies that showed increased MCarn in sprinters compared to non-76 
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sprinters (5), and increased MCarn in professional bodybuilders in comparison with untrained 77 
individuals (14). 78 
Although increased MCarn has been hypothesised to be an adaptation induced by long-79 
term high-intensity training (15), longitudinal studies from independent laboratories (16-22) 80 
have not shown any significant increase in MCarn following training. Limitations of these 81 
studies include lack of dietary control, lack of control for fibre type shifting and training 82 
protocols of insufficient intensity and/or duration. Since diet is one of the most influential 83 
factors affecting MCarn (7-10,19), any changes elicited by training may have been masked in 84 
studies where dietary beta-alanine intake was not controlled. Since type II fibres have ~50% 85 
more carnosine than type I fibres, training-induced changes in fibre type distribution and fibre 86 
cross-sectional area may have affect measured changes in MCarn. Furthermore, previous 87 
studies may have used training protocols of insufficient intensity (16,17) and/or duration (18-88 
22) to induce measurable increases in MCarn. Insufficient training stimuli appears to be critical 89 
in light of recent data suggesting that lactate and H+ may act as triggers for the skeletal muscle 90 
to adapt and improve H+ handling (23). Altogether, these limitations may have rendered 91 
previous studies unable to properly test the principle that chronic exercise training increases 92 
MCarn. In this proof-of-principle investigation, we used a very specific experimental set-up to 93 
test whether HIIT can increase MCarn. To provide sufficient training stimulus, we used a 12-94 
week HIIT protocol, longer than those previously shown to increase muscle buffering capacity 95 
(3,24); to control for the potential influence of diet and muscle fibre type shifting, only 96 
vegetarians were enrolled and MCarn was determined in individual muscle fibres. We 97 
hypothesised that HIIT would induce increases in MCarn, thereby explaining, at least in part, 98 
the enhanced muscle buffering capacity shown with this type of training. 99 
 100 
Methods 101 
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Participants 102 
 Twenty young, healthy vegetarian men volunteered to participate in this study. They 103 
were randomly assigned to either an untrained control (CON, n=10) or a HIIT (n=10) group, 104 
with groups being matched according to baseline maximal oxygen uptake (VO2max). One 105 
participant from the HIIT group withdrew from the study due to personal reasons unrelated to 106 
the study, meaning that 19 participants completed the study (CON, n=10; HIIT, n=9; (see Table, 107 
Supplemental Digital Content 1, which presents the participants' baseline characteristics). 108 
Inclusion criteria were: to be physically active (i.e., participation in non-structured exercise and 109 
sporting activities 1-3 times per week), and to have been on a vegetarian diet for at least one 110 
year prior to the study. Exclusion criteria were: sedentary lifestyle, diagnosed chronic diseases, 111 
use of any nutritional supplements 3 months prior to the study, participation in any structured 112 
training program 6 months prior to the study, smoking, and continued use of medications. 113 
Except for the training protocol for the HIIT group, all participants were requested to maintain 114 
similar levels of physical activity throughout the study; compliance with this request was 115 
verbally confirmed. They were also asked not to change their food habits, which was confirmed 116 
by food diaries. None of the participants consumed any food containing β-alanine across the 117 
study. Participants were fully informed about the risks associated with participation before 118 
completing a health screen and providing written consent. The study was approved by the 119 
Institutional Ethics Committee (Approval Number: 14647713.9.0000.5391) and conformed to 120 
the 2013 version of the Declaration of Helsinki. 121 
 122 
- PLEASE INSERT SUPPLEMENTAL DIGITAL CONTENT 1 HERE    -  123 
 124 
Experimental Design 125 
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 This was a randomised, controlled, parallel-group trial with participants assessed before 126 
(PRE) and after (POST) a 12-week intervention period comprising HIIT or no exercise training 127 
(control). Upon first arrival at the laboratory (1 week before the intervention), height, body 128 
mass and skinfold thicknesses were recorded, and a resting muscle biopsy was taken from the 129 
m. vastus lateralis; another muscle biopsy was taken 72-96 h after the intervention period had 130 
been completed. Muscle samples were analysed for the following parameters: whole muscle 131 
MCarn, isolated muscle fibre MCarn, in vitro muscle buffering capacity (βmin vitro), total protein, 132 
fibre type distribution and expression of selected genes. Exercise capacity was assessed PRE 133 
and POST using a graded exercise test (GXT) and a multiple-bout Wingate Test. Exercise 134 
training started within 7 days of the completion of the preliminary tests. Before and after the 135 
intervention period, food intake was assessed by three 24-h food diaries. 136 
 137 
Anthropometry 138 
Body mass was measured PRE and POST to the nearest 100 g on a digital scale (100 139 
CH, Welmy, São Paulo, Brasil). Height was measured on a wall-mounted stadiometer and 140 
skinfold thickness (Chest, Abdomen, Thigh) was measured in triplicate using a calibrated 141 
Harpenden caliper by the same experienced anthropometrist. Body density was calculated using 142 
the Jackson & Pollock equation (25) and %fat using the equation of Siri (26). 143 
 144 
Exercise capacity tests 145 
 GXT and multiple-bout Wingate Tests were conducted at least 48-h apart. Participants 146 
were asked to abstain from alcohol and exercise 48 h prior to all tests. Testing time was 147 
individually standardised. Participants were instructed to arrive at the laboratory 2-4 h post-148 
prandial. On the days preceding the post-intervention tests, participants were instructed to 149 
repeat the same meals, portion sizes and timing as per their PRE assessment. 150 
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Exercise capacity and aerobic fitness were determined by GXT before and after the 151 
intervention. The test was performed on an electronically-braked cycle ergometer (Excalibur 152 
Sport, Lode, Groningen, the Netherlands) and consisted of 4-min stages with a 1-min break 153 
between stages. The test intensity started at 50 W and increased by 30 W every 4 min until 154 
volitional exhaustion or until the participant could no longer maintain 70 rev×min-1. Strong 155 
verbal encouragement was provided to each participant as they approached the end of the test. 156 
Time to exhaustion was defined as the time completed during the test until fatigue, while 157 
maximum power output was determined as the highest power output achieved during the test. 158 
 Breath by breath concentrations of O2 and CO2 in expired air and ventilation were 159 
determined using a portable gas analysis system (K4b2, Cosmed, Rome, Italy), which was 160 
calibrated according to the manufacturer’s instructions before and verified after each test. 161 
VO2max was determined as the highest 30-s rolling VO2 average during the GXT. The first 162 
ventilatory (anaerobic) threshold was determined as the break point between the increase of 163 
carbon dioxide output (VCO2) and VO2. The second ventilatory threshold (respiratory 164 
compensation point) was determined as the lowest ventilatory equivalent for carbon dioxide 165 
(VE/VCO2 ratio) before a systematic increase. To determine lactate threshold, capillary blood 166 
samples were taken from fingertips in heparinized tubes at rest and immediately after each of 167 
the 4-min stages during GXT. Samples were immediately transferred to microtubes containing 168 
ice-cold 2% NaF and then centrifuged at 2000 g for 5 min at 4°C; plasma was kept at -85°C 169 
until analysis, which occurred in a single batch. Plasma lactate was determined 170 
spectrophotometrically (Victor 3/1420 Multi-Label Counter, PerkinElmer Inc., Massachusetts, 171 
United States of America) in micro-assays using an enzymatic method (Katal, Interteck, São 172 
Paulo, Brazil). Lactate threshold was calculated by the modified D-max method (27). 173 
High-intensity intermittent performance was assessed using 3 bouts of the 30-s lower-174 
body Wingate test interspersed by 3-min passive recovery periods. The test was conducted on 175 
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a mechanically-braked cycloergometer (Biotec 2100, Cefise, Brazil) with resistance being set 176 
at 5% of participant’s body mass. One habituation session was carried out at PRE, when the 177 
position on the cycle ergometer was individually recorded and replicated in all subsequent 178 
sessions. The testing protocol started following a standardised 5-min warm-up against no 179 
mechanical resistance. Strong verbal encouragement was given throughout every bout. Total 180 
mechanical Work Done (TWD) was calculated for the overall test session. The coefficient of 181 
variation (CV) for TWD was 2.8%. 182 
 183 
Muscle Biopsies 184 
 Muscle samples (~70-150 mg) were obtained under local anaesthesia (3 ml, 1% 185 
xylocaine) from the mid-portion of the m. vastus lateralis using the percutaneous needle biopsy 186 
technique with suction (28), as previously described (29). Samples were obtained PRE and 187 
POST from the same leg, as close as possible to one another, and were snap-frozen in liquid 188 
nitrogen, where they were stored until analysed. Samples were freeze-dried and dissected free 189 
of any visible blood, fat and connective tissue before being powdered. 190 
 191 
βmin vitro determination 192 
 The non-bicarbonate buffering capacity of skeletal muscle was determined using the 193 
homogenate titration method (3,24). An aliquot of ~2-3 mg of freeze-dried muscle was 194 
homogenised on ice for 3 min in a 10 mM NaF solution (100 µl for every 3 mg of dry muscle). 195 
Homogenates were placed in a 37°C water bath for 5 min before and during pH measurements. 196 
Muscle homogenate pH was measured using a glass microelectrode (Microelectrodes Inc. New 197 
Hamphsire, USA) attached to a digital pH meter (Fisher Scientific Accumet AB15). Muscle 198 
homogenates were initially adjusted to a pH of 7.1 with a 0.02 M NaOH solution and then 199 
titrated to a pH of 6.5 by the serial addition of 10 mM HCl. The final result is reported as 200 
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millimoles H+ per kilogram dry muscle required to change a whole pH unit (from 7.1 to 6.1 – 201 
βmin vitro). The CV for βmin vitro determined in our laboratory was 10.46% (in 12 muscle samples 202 
taken at rest from Wistar rats from an unrelated study). 203 
 204 
Chromatographic determination of total muscle and individual fibre carnosine content 205 
 Total MCarn content was quantified by high-performance liquid chromatography 206 
(HPLC - Hitachi, Hitachi Ltd., Tokyo, Japan) coupled to a U.V. detector, according to the 207 
method described by Mora et al. (30). Deproteinised muscle extracts were obtained from 3-5 208 
mg freeze-dried samples according to the protocol described by Harris et al. (7). The intra-assay 209 
CV for total MCarn in our samples was 1.34%. 210 
 To quantify carnosine in individual muscle fibres, a more sensitive, fluorescence-based 211 
method employing pre-column derivatisation was adapted from Dunnett & Harris (31). 212 
Approximately 20–40 single muscle fibres were isolated from each muscle sample. Two 0.5–213 
1.0 mm pieces were cut from each individual fibre; one piece was dissolved and stored 214 
overnight at 4oC in a sealed tube on a protein extraction buffer (15 µl of 0.06M tris-215 
hydroxymethyl-aminomethane pH 6.8, 1% w/v SDS, 0.6% w/v EDTA, 15% w/v glycerol, 5% 216 
v/v mercaptoethanol, and bromophenol blue) for myosin heavy chain isoform (MHC) 217 
characterisation via SDS-PAGE electrophoresis, as described by Hill et al. (8). The remainder 218 
of each fibre was weighed on a quartz-fibre fish-pole balance calibrated to 0.01 µg using DNA 219 
strands, the weights of which were determined after dissolving in 1 ml of water by comparison 220 
of the absorbance at 260 nm against a standard curve (absorbance vs. weight) prepared using 221 
the same material (8). 222 
 Each isolated fibre (or a pool of fibres of the same type) was extracted by the addition 223 
of 200 µL (or 300 µL) of ultrapure water and vortexed for 3 min. After preparing single fibre 224 
extracts, carnosine was determined using a Hypersil ODS (3 µm, 150X4.6 mm I.D.) analytical 225 
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column (Shandon, Runcom, UK), at 23°C, utilizing a binary gradient formed from solvent A 226 
[12.5 mM sodium acetate, pH 7.2 tetrahydrofuran (995:5, v/v)] and solvent B [12.5 mM sodium 227 
acetate, pH 7.2 - methanol-acetonitrile (500:350:150, v/v)]. Gradient composition was: 0 to 1.5 228 
min, 0% solvent B; 1.5 to 10 min, 35% B; 10 to 26 min, 60% B; 26 to 30 min, 100% B; 30 to 229 
35 min, 100% B; 35 to 45 min, 0% B. Flow-rate started at 2.0 ml×min-1 until 10 min, then 230 
gradually decreased to 1.0 ml×min-1 at 26 min until finish. Detector excitation and emission 231 
wavelengths were 340 nm and 450 nm. The derivatisation reagent was stored in the dark at 2°C 232 
and was prepared by mixing 80 µL of an OPA (40mg) plus absolute ethanol (800 µL) solution 233 
to 4 µL of β-mercaptoethanol and 1 mL of a 0.4M borate buffer (pH 9.65). For derivatisation, 234 
extract and reagent (1:1 v:v) were reacted for 30 s prior to injection. Fresh reagent was used 235 
with each new sample batch. Quantification of both chromatographic methods was performed 236 
using peak areas and regression equations obtained from standard curves. The intra-assay CV 237 
for carnosine determination in individual fibres was 4.97%. 238 
 239 
Total protein and whole muscle fibre-type distribution 240 
 Total protein was assessed in muscle extracts with the Bradford method using a 241 
commercially available kit and following manufacturer’s instructions (Bio-Rad, CA, USA). 242 
MHC was quantified in whole muscle following the same procedures above described for single 243 
fibres, where whole muscle samples were diluted in the same protein extraction buffer 244 
previously mentioned, and submitted to the same running conditions via SDS-PAGE 245 
electrophoresis. MHC I, IIa and IIx expression were individually quantified in arbitrary units 246 
with the aid of computer software (Scion Image) and subsequently normalised to the total 247 
arbitrary units within each sample. 248 
 249 
mRNA isolation, cDNA synthesis and quantitative polymerase-chain reaction (qPCR) 250 
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 Real time qPCR was used to determine the levels of expression of selected genes related 251 
to carnosine metabolism, namely, CARNS, CNDP2, ABAT, TauT and PAT1. Primer sets 252 
(forward and reverse) for the genes of interest were based on a previous study (32) (see Table, 253 
Supplemental Digital Content 2, which presents the primers sequences for gene expression 254 
analysis). Primer sequences were confirmed using in-silico analysis in a public database. 255 
Optimal primer concentrations and reaction conditions were determined for each pair of 256 
primers. Wet muscle samples (~20 mg) were homogenised using Trizol reagent (Invitrogen, 257 
Carlsbad, California), with RNA being isolated using the phenol-chloroform method. RNA 258 
concentrations and purity were determined using a micro spectrophotometer (NanoDrop 259 
ND2000, Thermo Scientific). RNA integrity was checked on a 1% agarose gel stained with 260 
ethidium bromide. The cDNA was synthesised using a specific cDNA reverse transcription kit 261 
solution (2X RT, Applied Biosystems, Thermo Fisher Scientific, Waltham, USA). 262 
 263 
- PLEASE INSERT SUPPLEMENTAL DIGITAL CONTENT 2 HERE    -  264 
 265 
 Real-time qPCR for each gene was performed in duplicate in a 100-µl microtube 266 
containing 5–20 ng cDNA, 11 µl SYBR Green Master Mix (Applied Biosystems), 100–400 267 
mM of each primer and ultra-pure water for a final volume of 22 µl. Gene expression analyses 268 
were carried out using the following cycle parameters: 95°C for 20 s; 40 cycles of 95°C for 3 269 
s, and 60°C for 30 s; melting curve consisted of a gradual ramp from 65 to 95°C at an increase 270 
of 1°C·s-1. Fluorescence intensity was quantified and amplification plots analysed by a 271 
sequence detector system (Rotor Gene-Q, Qiagen). Results were obtained using the 272 
comparative cycle threshold (Ct) method, as described by Bustin et al. (33). Non-template 273 
controls were included in all batches. 274 
 275 
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Food Intake Analysis 276 
 Food intake was assessed PRE and POST by three 24-h food diaries undertaken on 277 
separate days (two weekdays and one weekend day). Energy and macronutrient intakes were 278 
analysed with a computer software containing nutritional information about local food and 279 
ingredients (Virtual NutriTM, São Paulo, Brazil). All participants were instructed on how to 280 
complete food diaries by a trained nutritionist; they received a booklet containing instructions 281 
and real-sized photos of real food to help them record portion sizes. 282 
 283 
HIIT program 284 
 The HIIT intervention consisted of a progressive program undertaken three times per 285 
week (Monday, Wednesday and Friday) for 12 consecutive weeks. All training sessions were 286 
conducted on a mechanically-braked cycle ergometer (828E, Monark, Stockholm, Sweden) and 287 
were preceded by a 5-minute warm-up at 50 W. Training intensity was set as a percentage of 288 
LT and was based on previous intermittent training protocols that were effective in increasing 289 
βmin vitro (3,24). Exercise intensity was set at 140% (weeks 1 to 3), 150% (weeks 4 to 6), 160% 290 
(weeks 7 to 9) and 170% (weeks 10 to 12) of individual power at LT measured at PRE. 291 
Participants completed a variable number of 2-minute exercise bouts interspersed with 1-min 292 
passive recovery periods, as follows: 6 to 9 bouts during weeks 1 to 3, 8 to 10 bouts during 293 
weeks 4 to 6, 9 to 12 bouts during weeks 7 to 9, and 6 to 9 bouts during weeks 10 to 12. At the 294 
end of each training session, participants received a standardized snack to improve training 295 
adherence. Adherence rate to the training sessions was 95±7% (range: 80-100%). All 296 
participants were able to complete the entire training protocol within each session. 297 
 298 
Statistical Analysis 299 
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 Participant characteristics at PRE (body composition, food consumption, exercise 300 
capacity and intermittent performance, total protein content, βmin vitro, and MCarn) were 301 
compared between groups using unpaired t-Tests. These same variables, along with whole 302 
muscle MHC distribution and MCarn in fibre types, were analysed using Mixed Models with 303 
"group" (HIIT and CON) and "time" (PRE and POST) being fixed factors. Because only two 304 
pre-post pairs of data were obtained for type IIx fibres, neither within-group comparisons nor 305 
delta analysis were conducted for IIx fibres. Participants were random factors in all Mixed 306 
Models. Four different structures of covariance matrices were tested and the Bayesian 307 
information criterion (lowest BIC) was used to select the model that best fitted to each 308 
individual data set. Single degree of freedom contrast analysis was used for specific single-309 
effect comparisons. Unpaired T-tests were used to compare the absolute variation (i.e., post-pre 310 
delta) of the above-mentioned variables between groups. Effect sizes (ES) were calculated 311 
using Cohen's d; Qualitative descriptors for ES interpretation were assigned as follows: <0.2, 312 
negligible effect; 0.2 - 0.39, small effect; 0.40 - 0.75, moderate effect; >0.75, large effect. 313 
Analyses were conducted using the SAS software v. 9.3. The significance level set was P ≤ 0.05 314 
and marginally significant effects were considered when P ≤ 0.1. Data are presented as mean ± 315 
standard-deviation, delta change, ES, and 95% confidence interval (CI). 316 
 317 
Results 318 
Effects of HIIT on MCarn in whole muscle 319 
 No significant differences between groups were observed for MCarn in whole muscle 320 
before training (CON: 14.3±5.3 mmol·kg-1 vs. HIIT: 15.8±5.7 mmol·kg-1; p=0.98). MCarn 321 
significantly increased by +4.5±3.3 mmol·kg-1 (+35.7%) after training in the HIIT group 322 
(group-by-time interaction: F=4.72; p=0.049; within-group effect: p=0.012; ES=0.87; 95%CI=-323 
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0.09 to 1.85), but not in the CON group (+0.3±4.4 mmol·kg-1; +6.3%, within-group effect: 324 
p=0.99; ES=0.14; 95%CI=-0.78 to 1.08) (Figure 1). 325 
 326 
- PLEASE INSERT FIGURE 1 HERE    -  327 
 328 
Effects of HIIT on MCarn in fibre types 329 
No significant differences between groups were shown at PRE for MCarn in type I 330 
(p=0.99), IIa (p=0.97) or IIx (p=0.98) muscle fibres. On the other hand, MCarn was 331 
significantly lower at PRE in type I fibres compared to type IIa and IIx (both P<0.05), with no 332 
significant difference in MCarn between type IIa and IIx (P>0.05). In type I fibres, a +2.7±3.3 333 
mmol·kg-1 (+24.2%) increase in MCarn was shown in the HIIT (group-by-time interaction: 334 
F=3.78; p=0.067; within-group effect: p=0.047; ES=0.36; 95%CI=0.07 to 0.65) but not in the 335 
CON group (+0.2±2.0 mmol·kg-1; +1.48%, within-group effect: p=0.99; ES=0.17; 95%CI=-336 
0.12 to 0.46) (Figure 2). In type IIa fibres, a significant +2.1±2.2 mmol·kg-1 (+13.8%) increase 337 
in MCarn was shown in the HIIT (group-by-time interaction: F=9.52; p=0.006; within-group 338 
effect: p=0.067; ES=0.28; 95%CI=0.02 to 0.54), but not in the CON group (-1.2±2.1 mmol·kg-339 
1; -5.64%, p=0.37; ES=-0.22; 95%CI=-0.49 to 0.05) (Figure 2). Analysis of the absolute change 340 
(delta post-pre) showed a significant difference between groups (p=0.007) in Type IIa fibres 341 
(+2.04 ± 2.24 mmol·kg-1 in the HIIT group vs. -1.21 ± 2.08 mmol·kg-1 in the CON group). In 342 
type I fibres, an increase of similar magnitude was shown in the HIIT (+2.70 ± 3.27 mmol·kg-343 
1) but not in the CON group (+0.16 ± 2.02 mmol·kg-1 in the CON group), although this only 344 
approached significance (p=0.084) (figure 2). 345 
 346 
- PLEASE INSERT FIGURE 2 HERE    -  347 
 348 
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Effects of HIIT on βmin vitro 349 
 Although, a significant between-group difference was shown at PRE (p=0.018), a 350 
significant group-by-time interaction was shown for βmin vitro (F=7.30; p=0.02). A within-group 351 
effect was demonstrated for HIIT (p=0.047; ES=1.20; 95%CI=0.09 to 2.21), but not for CON 352 
(p=0.413; ES=-0.80; 95%CI=-1.77 to 0.16) (Figure 3, upper panel). Analysis of the absolute 353 
change showed a significant difference between groups (p=0.033) in βmin vitro (+44.1 ± 53.8 354 
mmol H+·kg dm-1·pH unit-1) in the HIIT group vs. -36.3 ± 40.5 mmol H+·kg dm-1·pH unit-1 in 355 
the CON group). 356 
 357 
- PLEASE INSERT FIGURE 3 HERE    -  358 
 359 
Effects of HIIT on total protein content 360 
 No significant differences between groups for total protein were shown at PRE (CON: 361 
1.79 ± 1.45 µg.µL-1 vs. HIIT: 1.24 ± 0.68 mg.µL-1 - p=0.99), and no significant group-by-time 362 
interaction effect was shown for total protein content (F=0.37; p=0.55; Figure 2, bottom panel). 363 
Analysis of the absolute change showed no significant difference between groups (p=0.670) for 364 
total protein content (-0.21 ± 1.57 mg.µL-1 in the HIIT group vs. -0.55 ± 1.82 mg.µL-1 in the 365 
CON group). 366 
 367 
Effects of HIIT on MHC shifting 368 
 No significant differences between groups were shown for MHC expression at PRE (all 369 
p>0.05). Type I MHC expression significantly decreased -5.5±7.2% in the HIIT group (group-370 
by-time interaction: F=4.94; p=0.043; within-group effect: p=0.08; ES=-0.83; 95%CI=-1.86 to 371 
0.19), but not the in the CON group (+2.1±4.9%; within-group effect: p=0.449; ES=0.08; 372 
95%CI=-0.9 to 1.07). This was paralleled by a trend towards a significant within-group effect 373 
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in type IIa MHC expression in the HIIT group (+4.5±7.7%; group-by-time interaction: F=1.48; 374 
p=0.241; within-group effect: p=0.09; ES=0.48; 95%CI=-0.51 to 1.48), but not in the CON 375 
group (+0.5±3.9%; within-group effect: p=0.97; ES=0.03; 95%CI=-0.95 to 1.02). Type IIx 376 
MHC expression did not change in any of the groups (CON group: -2.6±4.6%; ES=-0.16; 377 
95%CI=-1.18 to 0.86; HIIT group: +1.3±12.9%; ES=0.16; 95%CI=-0.86 to 1.18) (Table 1). 378 
 379 
- PLEASE INSERT TABLE 1 HERE    -  380 
 381 
Effects of HIIT on the expression of selected genes in the skeletal muscle 382 
 No significant changes were shown for the expression of the genes CNDP-2, ABAT, 383 
TauT, PAT1 and CARNS (group-by-time interaction effects: all p>0.05) (Figure 4). 384 
 385 
- PLEASE INSERT FIGURE 4 HERE    -  386 
 387 
Effects of HIIT on exercise capacity 388 
 There was a significant +10.1% (+3907 J) improvement in TWD in the HIIT group 389 
(group-by-time interaction effect: F=22.96, p=0.0003; within-group effect: p<0.0001; ES=0.99; 390 
95%CI=0.01 to 1.98) but not in the CON group (-2.17%, -1010 J, p=0.20; ES=-0.09; 95%CI=-391 
1.02 to 0.83). The absolute change in TWD was significantly different between groups 392 
(p=0.0003; Figure 5). There was a significant +23.7% (+401 s) increase in time-to-exhaustion 393 
in the HIIT group (group-by-time interaction: F=5.40; p=0.027; within-group effect: p=0.004; 394 
ES=1.32; 95%CI=0.30 to 2.34) but not in the CON group (+0.6%; +9 s, p=0.78; ES=-0.17; 395 
95%CI=-1.10 to 0.75). HIIT significantly increased maximum power output by 21.1% (+41.25 396 
W; group-by-time interaction: F=6.67; p=0.015; within-group effect: p=0.003; ES=1.29; 397 
95%CI=0.27 to 2.31), whilst no changes were shown for the CON group (-2.2%; -5 W, within 398 
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group effect: p=0.58; ES=-0.16; 95%CI=-1.34 to 0.53). The absolute change in time-to-399 
exhaustion (p=0.0002) and maximum power output (p=0.0004) were significantly different 400 
between groups (Figure 5). 401 
 402 
- PLEASE INSERT FIGURE 5 HERE    -  403 
 404 
Effects of HIIT on VO2max and ventilatory thresholds 405 
 No group-by-time interaction was shown for VO2max (F=0.98; p=0.32). However, a 406 
significant difference between groups (p=0.045) was found for delta VO2max, with the HIIT 407 
group showing a +3.25 ml·kg-1·min-1 increase (+8.11%; ES=0.52; 95%CI=-0.42 to 1.46) 408 
following training whereas the CON group showed a +0.65 ml·kg-1·min-1 increase (+1.58%; 409 
ES=0.09; 95%CI=-1.03 to 0.83; Figure 5). 410 
 Time to reach the 1st and the 2nd VT were +43.8% and +19.4% longer after the 411 
intervention in the HIIT group (group-by-time interaction: F=6.04, p=0.020 and F=5.63, 412 
p=0.024, for the 1st and 2nd VT respectively; within-group effect: p=0.012; ES=1.14; 413 
95%CI=0.14 to 2.14 and p=0.014; ES=1.08; 95%CI=0.09 to 2.08, for the 1st and 2nd VT 414 
respectively), but not in the CON group (within-group effect: -9.57%, p=0.39; ES=-0.36; 415 
95%CI=-1.49 to 0.40 and -5.13%, p=0.42; ES=-0.35; 95%CI=-1.29 to 0.58 for the 1st and 2nd 416 
VT, respectively). Significant differences were shown between groups for the delta changes in 417 
the time to reach the 1st and 2nd VT (both p=0.009; both in Figure 5). 418 
 419 
Effects of HIIT on body weight and body fat percentage 420 
 There was no group-by-time interaction for body weight (F=0.85; p=0.37) or body fat 421 
percentage (F = 0.23; p=0.63). Similarly, there were no significant differences between groups 422 
in the absolute changes in body weight (p=0.40) or body fat percentage (p=0.64). 423 
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 424 
Food intake 425 
 No main effects or interaction effects were shown for calories and macronutrient intake 426 
between groups across the study (see Table, Supplemental Digital Content 3, which presents 427 
the food consumption data). 428 
 429 
- PLEASE INSERT SUPPLEMENTAL DIGITAL CONTENT 3 HERE    -  430 
 431 
Discussion 432 
 Using robust methods and a tightly controlled experimental design, we were able to 433 
prove, for the first time, the principle that chronic high-intensity exercise training increases 434 
MCarn, which occurs independently of dietary supply of β-alanine. Increased MCarn, therefore, 435 
seems to be part of the milieu of muscle adaptive responses to HIIT. Since increased MCarn 436 
was independent of dietary or supplemental intake of β-alanine, it must have resulted from 437 
intrinsic changes in the skeletal muscle, which is supported by the significant increase shown 438 
in both type I and II individual fibres. These findings are particularly relevant, since the adaptive 439 
response of MCarn to high-intensity training has remained doubtful, with evidence for 440 
increased MCarn being limited to cross-sectional studies and not confirmed by interventional 441 
studies.  442 
 Several longitudinal studies did not show increased MCarn with exercise training. These 443 
studies have limitations, however, including a lack of control for dietary intake of β-alanine 444 
(the most influential factor on MCarn) (7-9) and the use of training protocols of insufficient 445 
volume (18-22) and/or intensity (16,17) unlikely to result in significant changes in MCarn. This 446 
argument is supported by cross-sectional studies suggesting increased MCarn could be an 447 
adaptive response to long-term high-intensity, but not endurance, training (5). Only one of these 448 
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studies (18) measured MCarn in isolated muscle fibre types, meaning that most studies did not 449 
account for changes in fibre distribution induced by training. Nonetheless, the only study that 450 
measured carnosine in fibre types did not control dietary intake of β-alanine. Thus, previous 451 
studies may have lacked sufficient sensitivity and control to determine changes in MCarn 452 
content with training.  453 
 In the present study, our training protocol increased TWD, time-to-exhaustion, 454 
maximum power output, VO2max, and the 1st and 2nd VT, thereby confirming the efficacy of our 455 
intervention. HIIT also increased whole muscle MCarn by 35%, with this increase not 456 
accounted for by diet, since we exclusively recruited vegetarian participants who consumed 457 
virtually no β-alanine/carnosine. The inclusion of vegetarians only, along with the individual 458 
fibre type analysis, were intentionally chosen in our experimental set-up, as it would allow us 459 
to more conclusively test the principle that chronic high-intensity exercise training increases 460 
MCarn. Although similar increases in MCarn may not necessarily occur in omnivores, or may 461 
not be detectable if these variables are not controlled, our results clearly show that the principle 462 
holds true that training can increase MCarn content in the absence of β-alanine ingestion. 463 
Baseline MCarn content was lower than those we have previously shown in omnivores (~15 464 
vs. 23 mmol·kg-1dm (9). The mean increases shown here (4.61 ± 3.05 mmol·kg-1dm) are 465 
approximately one third of those shown following 4 weeks of β-alanine supplementation at high 466 
doses (7-9). Furthermore, there was a ~5% reduction in type I and a ~5% increase in type II 467 
fibres in response to HIIT, which is line with other studies showing a reduction in type I MHC 468 
and an increase in type IIa MHC after sprint training (34). This could have been a confounding 469 
factor in the interpretation of the role of training on carnosine synthesis. Our results confirm 470 
previous studies (8, 13, 18), showing that type II fibres have ~1.5 times more carnosine than 471 
type I fibres, meaning that fibre shifting accounted for an ~10% increase in whole muscle 472 
MCarn in this study. The remaining increase in MCarn (~25%) can be almost entirely attributed 473 
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to the increased MCarn content in individual muscle fibres. Interestingly, our data demonstrate 474 
that absolute increases in MCarn with HIIT is similar between different fibre types which is in 475 
line with results following β-alanine supplementation (8). This strengthens the notion that fibre 476 
types, despite having different baseline carnosine contents, seem to respond similarly to stimuli 477 
that lead to increased carnosine. The cellular and molecular mechanisms responsible for such 478 
differences in baseline carnosine content between fibre types, and for the similarities in 479 
carnosine responses to different stimuli (e.g., supplementation and training), remain unknown. 480 
 To explore mechanisms that could account for increased MCarn content within the 481 
skeletal muscle, we quantified the expression of genes involved in carnosine homeostasis.  482 
None of the investigated genes showed altered expression in response to training. It must be 483 
noted that gene expression does not necessarily represent alterations in protein content and, 484 
most importantly, the biological activity of the protein. However, we did not have enough 485 
sample to carry out the analyses of protein content and enzymatic activity, which we 486 
acknowledge as a limitation in this study. Furthermore, gene expression was determined at one 487 
time point 72-96 hours following the last training session, which does not exclude the 488 
possibility that changes in gene expression could have occurred at different time points. 489 
Increased MCarn can only be a consequence of increased synthesis, decreased degradation, or 490 
both. Considering our vegetarian sample had virtually zero dietary intake of β-alanine, 491 
increased synthesis could only be possible if the endogenous production of β-alanine increased 492 
with training, or that its degradation within muscle decreased with training. Assuming that the 493 
conversion of β-ureidopropionate to β-alanine in the liver is 10 µmol·h-1 (35), and that 1 kg of 494 
dry muscle is equivalent to 4.3 kg of wet muscle, a ~5 mmol·kg-1 dry muscle increase in 495 
carnosine (~50 mmol increase in a 70-kg individual with 40 kg of wet muscle) would require 496 
the β-alanine synthesis rate to increase ~2.5 times above baseline in order to provide substrate 497 
for the synthesis of 50 mmol of carnosine (assuming no losses of β-alanine). Other possible 498 
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pathways for β-alanine synthesis is the decarboxylation of aspartate to produce β-alanine in 499 
kidneys or muscle via GADL1 activity (36), the transamination of malonate semialdehyde to 500 
produce β-alanine via beta-alanine aminotransferase, or the transamination of L-alanine to form 501 
β-alanine via β-alanine-pyruvate transaminase. Although not determined herein, the activities 502 
of these enzymes could have been affected by training. In addition to increased β-alanine 503 
synthesis, another and perhaps more plausible explanation is a reduction in carnosine 504 
degradation in muscle in response to HIIT. Other mechanisms might involve increased β-505 
alanine transport into skeletal muscle cells, perhaps triggered by increased blood flow. These 506 
are only speculative, however, and future studies should be specifically designed to explore the 507 
underpinning effects of exercise on muscle carnosine turnover. 508 
Previous studies have shown increased muscle buffering capacity following high-509 
intensity training (3,24,37,38). Our results corroborate and further confirm these findings; this 510 
is particularly important in our study since it serves as a positive control to ensure that our HIIT 511 
protocol elicited an adaptation that could be explained by changes in MCarn. We employed the 512 
same HIIT protocol as Edge et al. (3,24), who showed a 25% and 31% increase in βmin vitro after 513 
5 and 8 weeks; extending this to 12 weeks, our study resulted in a ~40% increase in βmin vitro 514 
(see Figure, Supplemental Digital Content 4, which shows an association between absolute 515 
changes in βmin vitro and the duration of exercise training). The maximum change that an increase 516 
of ~4 mmol·kg-1 in carnosine would incur for βmin vitro is ~1.3 mmolH+·kg-1; this accounts for 517 
~3% of the total increase in βmin vitro (~44 mmolH+·kg-1 induced by HIIT), suggesting that 518 
increased carnosine accounts for a minor part of this response. However, the titration method 519 
does not provide an accurate measure of true physiochemical buffering capacity. 520 
Homogenisation of muscle results in PCr and ATP hydrolysis leading to increases in inorganic 521 
and hexose monophosphates (pKas 6.1-6.8), which contribute to an overestimation of muscle 522 
buffering capacity (39). Thus, any attempt to calculate the contribution of carnosine to the 523 
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measured βmin vitro would fundamentally underestimate the true contribution of carnosine, 524 
meaning caution should be exercised when interpreting these data. 525 
Although a precise quantification of the contribution of increased MCarn to the 526 
increased βmin vitro is not possible, it is very unlikely that increased MCarn is accountable for 527 
the entire increase in βmin vitro; therefore, other intrinsic changes in skeletal muscle induced by 528 
HIIT must have occurred to account for the total increase in βmin vitro. We measured total protein 529 
in muscle extracts, since they exert some buffering action, although our results indicate that 530 
increased protein is not part of this response. Other possibilities include increased phosphates, 531 
and proteins rich in histidine residues (the only amino acid capable of contributing to βmin vitro 532 
over this pH range), such as myoglobin. These have not been measured in our study and future 533 
studies should explore what exact mechanisms beyond increased carnosine that fully account 534 
for the increase in βmin vitro. Metabolomic studies could help to identify ionisable compounds 535 
with pKa close to the physiological transit-range that are responsive to HIIT-type interventions. 536 
 537 
- PLEASE INSERT SUPPLEMENTAL DIGITAL CONTENT 4 HERE    -  538 
 539 
In conclusion, this study demonstrated that HIIT increases MCarn in whole muscle and 540 
in isolated muscle fibre types, independent of diet. Whether HIIT can elicit similar effects in 541 
omnivores, this still merits further investigation. These results challenge the current belief that 542 
exercise training cannot increase MCarn content and demonstrate that this can occur in the 543 
absence of β-alanine/carnosine ingestion (7-9). These novel data demonstrate that the increase 544 
in MCarn accounts for a small part of the total increase in muscle buffering capacity with HIIT. 545 
The increase in MCarn induced by training corresponds, in absolute values, to one-third of the 546 
typical increase brought about by β-alanine supplementation; it is driven not only by fibre type 547 
shift, but also by an intrinsic increase in MCarn that occurs in both type I and type II fibres and 548 
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does not depend on the dietary supply of β-alanine. Further research should determine whether 549 
this exercise training protocol elicits similar or greater increases in muscle carnosine content in 550 
individuals who ingest beta-alanine in their diet. In addition, further research should examine 551 
whether these responses are affected by training status and which types of exercise training (e.g. 552 
different intensities and volumes) elicit the greatest accumulation of MCarn. 553 
 554 
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Figures captions 738 
 739 
Figure 1. Effects of high-intensity interval training (HIIT) on muscle carnosine content 740 
measured in whole muscle. 741 
 742 
Figure 2. Effects of high-intensity interval training (HIIT) on carnosine content measured in 743 
individual fibres grouped by type. No delta analyses were carried-out for type IIx fibres due to 744 
the low number of pre-post pairs of data. 745 
 746 
Figure 3. Effects of high-intensity interval training (HIIT) on muscle buffering capacity 747 
measured in vitro (βmin vitro) (upper panel) and on total protein content (bottom panel). 748 
 749 
Figure 4: Gene expression of carnosinase-2 (CNDP-2), beta-alanine transaminase (ABAT), 750 
taurine transporter (TauT), proton/amino acid transporter-1 (PAT1) and carnosine-synthase 751 
(CARNS). Data are expressed as means and standard deviation of fold change at POST with 752 
levels at PRE for both groups arbitrarily set to 1. 753 
 754 
Figure 5: Absolute change in total work done (TWD), time-to-exhaustion, mean power output 755 
(MPO), maximal oxygen consumption (VO2max), and time to reach the 1st and 2nd ventilatory 756 
thresholds (VT) in the Control (white bars) and Trained (black bars) groups. 757 
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Supplemental Digital Content 4, Figure.tif Illustration of absolute changes in muscle 787 
buffering capacity in vitro (βmin vitro) during weeks of exercise training (data adapted from: Edge 788 
et al. 2006b; Edge et al. 2006c). A positive and high correlation was observed between the 789 
parameters (R2=0.89). To estimate βmin vitro (which is the estimated βm over 1 full pH change, 790 
data from the present study has been adjusted by dividing by 0.6, in accordance with the 791 
procedure used in the two studies by Edge et al.). 792 
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SDC 1 794 
 795 
 796 
 HIIT 
(n=9) 
CONTROL 
(n=10) p 
Age (y) 27±6 29±6 0.56 
Body weight (kg) 73.4±9.7 70.3±9.9 0.47 
Height (m) 1.78±0.06 1.77±0.06 0.88 
BMI (kg/m2) 23.5±3.0 22.1±2.1 0.26 
Time on vegeterian diet (y) 3.5±3.0  5.1±4.2  0.31  
Wmax (W) 233.3±40.9 209.0±24.7 0.14 
Time to exhaustion (s) 1970±371 1682±259 0.09 
Time to 1st VT (s) 1413±429 1107±261 0.08 
Time to 2nd VT (s) 1873±355 1473±212 0.01 
VO2max (ml.kg-1.min-1) 40.05±6.21 39.14±3.28 0.69 
HRmax (beats×min-1) 193±6 191±6 0.50 
TWD - Wingate (J) 38827±5957 36448±6832 0.41 
Body fat (%) 15.6±6.7 12.6±3.5 0.26 
Data are expressed as mean ± standard-deviation. BMI: body mass index; Wmax: maximum power 797 
output; 2nd VT: second ventilatory threshold; VO2max: maximum oxygen consumption; FCmax: maximum 798 
heart rate; TWD: total work done; βmin vitro: muscle buffering capacity in vitro. 799 
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SDC 2 802 
 803 
Gene FWD primer sequence REV primer sequence 
CARNS 5’-GGCGTCAGCAAGAAGTTCGT-3’ 5’-CCGGTGCTCTGTCATGTCAA-3’ 
CNDP2 5’-TTGCTGATGGGCTCTTTGGT-3’ 5’-TCGATGTCGTCGTACAGCTTGT-3’ 
ABAT 5’-CGCACTCTAAAGCCATTCAC-3’ 5’-AGATCCTCCACCTCTTCCA-3’ 
TauT 5’-CGTACCCCTGACCTACAACAAA-3’ 5’-CAGAGGCGGATGACGATGAC-3’ 
PAT1 5’-CATAACCCTCAACCTGCCCAAC-3’ 5’-GGGACGTAGAACTGGAGTGC-3’ 
EEF1A1 (reference gene) 5’-CTGGCAAGGTCACCAAGTCT-3’ 5’-CCGTTCTTCCACCACTGAT-3’ 
CARNS - carnosine sintase; CNDP2 - carnosinase isoform 2; ABAT - beta-alanine transaminase; TauT - 804 
taurine transporter; PAT1 - proton-dependent amino acid transporter; EEF1A1 - Eukaryotic Translation 805 
Elongation Factor 1 Alpha 1. 806 
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SDC 3 809 
 810 
 811 
 
HIIT CON p* 
 
PRE POST PRE POST 
 
Energy 
(kcal) 
2717 ± 1066 2588 ± 899 2041 ± 430 1961 ± 438 0.81 
Protein (g) 60.3 ± 32.4 80.7 ± 28.5 84.2 ± 57.9 73.2 ± 28.2 0.23 
Protein (%) 11.4 ± 4.5 13.1 ± 4.3 13.1 ± 3.6 14.0 ± 4.4 0.82 
CHO (g) 461.3 ± 272.0 406.0 ± 235.9 331.8 ± 102.7 275.0 ± 58.4 0.82 
CHO (%) 62.5 ± 12.2 60.2 ± 15.8 56.1 ± 5.9 55.8 ± 6.5 0.65 
Fat (g) 76.1 ± 28.4 71.3 ± 44.4 85.3 ± 44.6 67.8 ± 25.9 0.47 
Fat (%) 30.9 ± 8.2 26.6 ± 12.7 30.8 ± 5.5 26.1 ± 10.2 0.49 
Protein/kg 0.99 ± 0.43 1.10 ± 0.50 0.94 ± 0.27 1.07 ± 0.41 0.91 
Data are expressed as mean ± standard-deviation. No significant differences were observed. 812 
* p values represent the Group x Time interaction. CHO=carbohydrate. 813 
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SDC 4 816 
 817 
 818 
